CD1D and neoplasm: Because CD8+ TILs are known to back the enhancement of antitumoral immunity [28], we explored the abundance of intratumoral degranulation marker CD107a+ CD8+ T cells in CD1d−/− mice nourished with a control or WTMCGEP diet 28 days after tumor challenge.